These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23321608)

  • 1. MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases.
    Pers YM; Jorgensen C
    Nat Rev Rheumatol; 2013 Feb; 9(2):76-8. PubMed ID: 23321608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic agents and their use in resource-poor countries.
    Adebajo A; Fursts DE
    J Rheumatol; 2005 Jul; 32(7):1182-3. PubMed ID: 15996048
    [No Abstract]   [Full Text] [Related]  

  • 3. 50th volume--60 years. A golden year.
    Scott DG; Moots RJ
    Rheumatology (Oxford); 2011 Jan; 50(1):1-3. PubMed ID: 21148152
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic treatment of pediatric rheumatic diseases: are we spoilt for choice?
    van Royen-Kerkhof A; Vastert BS; Swart JF; Wulffraat NM
    Immunotherapy; 2014; 6(1):1-3. PubMed ID: 24341875
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological therapies in rheumatic diseases.
    Conti F; Ceccarelli F; Massaro L; Cipriano E; Di Franco M; Alessandri C; Spinelli FR; Scrivo R
    Clin Ter; 2013; 164(5):e413-28. PubMed ID: 24217844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatic diseases in children].
    Bader-Meunier B
    Soins Pediatr Pueric; 2012; (269):14-6. PubMed ID: 23297590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in autoimmune rheumatic diseases.
    Galeazzi M; Balistreri E; Giannitti C; Sebastiani GD
    Reumatismo; 2012 Mar; 64(1):7-17. PubMed ID: 22472778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nutrition in rheumatic-type diseases].
    Hahn A; Ströhle A; Wolters M
    Med Monatsschr Pharm; 2007 Apr; 30(4):138-46; quiz 147-8. PubMed ID: 17484444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological therapy of rheumatism].
    SCHARFBILLIG C
    Dtsch Med J; 1952 Aug; 3(15-16):340-2. PubMed ID: 12988958
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms in adverse reactions to food. The joints and muscles.
    Panush RS; Veloso ML; Weiss S; Bielory L
    Allergy; 1995; 50(20 Suppl):74-7. PubMed ID: 7741210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dawn of the era of biologics in the treatment of the rheumatic diseases.
    Koopman WJ
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S75-8. PubMed ID: 18240221
    [No Abstract]   [Full Text] [Related]  

  • 12. A glimpse into the future: recombinant proteins and small molecules for targeted therapies in rheumatic diseases.
    Kalden JR; Braun J
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S168-70. PubMed ID: 19822067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental rheumatology--on the way to a fundamental understanding of rheumatic diseases].
    Radbruch A
    Z Rheumatol; 2005 Sep; 64(6):367-9. PubMed ID: 16184342
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatic disease and cystic fibrosis.
    Merkel PA
    Arthritis Rheum; 1999 Aug; 42(8):1563-71. PubMed ID: 10446852
    [No Abstract]   [Full Text] [Related]  

  • 15. Updating the Italian Society for Rheumatology recommendations for biologic therapy in adult patients with inflammatory rheumatic diseases.
    Montecucco C; Caporali R; Matucci-Cerinic M
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S3-6. PubMed ID: 21906422
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?
    Bell GM; Reynolds G; Isaacs JD
    Nat Rev Rheumatol; 2011 Aug; 7(9):507-16. PubMed ID: 21808288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T-cell antigen receptors in rheumatic disease.
    Li ZG; Manolios N
    Aust N Z J Med; 1993 Apr; 23(2):205-12. PubMed ID: 8517845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of imaging in monitoring biologic therapy.
    Freeston JE; Emery P
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):2-3. PubMed ID: 17202999
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome measures in inflammatory rheumatic diseases.
    Fransen J; van Riel PL
    Arthritis Res Ther; 2009; 11(5):244. PubMed ID: 19849821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of biological agents and tissue engineering approaches on the treatment of rheumatic diseases.
    da Silva MA; Martins A; Teixeira AA; Reis RL; Neves NM
    Tissue Eng Part B Rev; 2010 Jun; 16(3):331-9. PubMed ID: 20025434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.